The G-protein coupled receptors (GPCRs) market is set to witness accelerated growth over the next decade. Advancements in molecular research and protein studies have been at the forefront of market maturity. Furthermore, cellular analysis is also an important application of these proteins. Medical researchers pay immense attention on the study of the cell membrane, and other parts of the cell. Furthermore, cellular responses of the body can help in diagnosing and detecting a number of diseases and disorders. Therefore, the global G-protein coupled receptors (GPCRs) market is expected to attract voluminous revenues in the years to follow. The large protein family that falls under this class of receptors has become a matter of discussion across the medical fraternity.

Study of various pathways for signal transduction involves the use of G-protein coupled receptors (GPCRs). Furthermore, these protein receptors help in conducting cellular research, and in studying the function of the cell membrane. The field of medical research has become the epicentre of advancements within healthcare. New lines of treatments can be conceptualised through intensive research across medical sciences. Besides, rising incidence of bone diseases and disorders has compelled the medical industry to improve its functional dynamics. On account of the aforementioned factors, it is safe to prognosticate the inflow of fresh revenues into the global G-protein coupled receptors (GPCRs) market.

Advancements in Physiology to Drive Market Demand

Application of G-protein coupled receptors (GPCRs) in the domain of physiology has emerged as an important dynamic of market growth. Regulation of the immune system involves the use of protein receptors. Furthermore, control of inflammation in the human body at the hands of chemokine receptors shall help in driving market demand. The vendors in the global G-protein coupled receptors (GPCRs) market are expected to capitalise on the gaps existing in medical research. The ability to meet the requirements of the research fraternity shall play a defining role in driving market demand.

Treatment of tumours is a defining metric to gauge the effectiveness of the medical fraternity. Moreover, growth and metastasis of tumours needs to be decoded in order to develop effective treatment lines. This factor, coupled with advancements in protein structure analysis, shall fetch fresh revenues for the market players. Recognition of hormones and processing of odours are amongst other key applications of G-protein coupled receptors (GPCRs). Scientists across the globe are making ardent efforts to discover new applications of G-protein coupled receptors (GPCRs). The medical fraternity shall contribute towards the market growth and maturity in the coming times. The swiftness of these receptors in terms of activation is amongst their most splendid attributes.

Focus on Treating Cardiovascular and Immune Diseases

On the basis of therapeutic areas, the global G-protein coupled receptors (GPCRs) market can be segmented into central nervous system, cardiovascular system, immune system, respiratory system, oncology, and reproductive system. The uncontested need for improved treatment lines in each of the aforementioned areas shall aid market growth. Oncological research has become an important area of research within medicine. Moreover, GPCRs hold tremendous relevance in treating disorders related to the respiratory system and central nervous system. Advancements in gynaecology shall also unfurl fresh opportunities for growth and advancement within the global market.

North America Market to Expand with Advancements in Oncology

On the basis of geography, the global G-protein coupled receptors (GPCRs) market can be segmented into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. The North America market is slated to tread along a lucrative track in the years to follow. Advancements in oncological research across the US has created tremendous opportunities for regional market growth.

Some of the leading vendors in the global G-protein coupled receptors (GPCRs) market are Thermo Fisher Scientific, Inc., Becton, and Dickinson and Company/

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global G-Protein Coupled Receptors (GPCRs) Market
2.2 Comparative Analysis: Global GPCRs Market Revenue, by Geography, 2013 & 2022 (Value %)
 
Chapter 3 Global G-Protein Coupled Receptors (GPCRs) Market Overview
3.1 Introduction
3.2 Market Drivers
      3.2.1 Rising Demand for Advanced/Improved GPCR Assays, Assay Systems and Platforms in Ever Growing Drug Discovery and ADME Toxicity Studies Worldwide
      3.2.2 High Prevalence and Incidence of Cardiovascular, Respiratory, and Reproductive Conditions along with Rising Occurrence of Cancers and Nervous System Disorders Globally
      3.2.3 Increased Government Initiatives and Partnerships/ Collaborations are Likely to Boost Demand for Technologically Advanced GPCR Assays and Assay Systems Worldwide
3.3 Market Restraints
      3.3.1 High Cost Involved in the Maintenance of Cell Lines and Costly Equipment and Instruments could Restrain Demand for GPCR Assays
3.4 Market Opportunities
      3.4.1 Development of Technologically Advanced GPCR Assays, Assay Systems and Assay Platforms
3.5 Porter’s Five Forces Analysis: Global GPCRs Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Value Chain Analysis: GPCRs Market
3.7 Market Attractiveness Analysis: Global GPCRs Market, by Geography
3.8 Competitive Landscape
      3.8.1 Market Share Analysis, by Key Players: Global GPCRs Market, 2013 (Value %)
 
Chapter 4 Global G-Protein Coupled Receptors (GPCRs) Market, by Assay Type
4.1 Introduction
      4.1.1 Global GPCRs Market Revenue, by Assay Type, 2012 – 2022 (USD Million)
      4.1.2 Comparative Analysis: Global GPCRs Market Revenue, by Assay Type, 2013 & 2022 (Value %)
4.2 Calcium Level Detection Assays
      4.2.1 Global Calcium Level Detection Assays Market Revenue, 2012 – 2022 (USD Million)
4.3 GTPγS Binding Assays
      4.3.1 Global GTPγS Binding Assays Market Revenue, 2012 – 2022 (USD Million)
4.4 cGMP Assays
      4.4.1 Global cGMP Assays Market Revenue, 2012 – 2022 (USD Million)
4.5 Reporter Gene Assays
      4.5.1 Global Reporter Gene Assays Market Revenue, 2012 – 2022 (USD Million)
4.6 Receptor Internalization Assays
      4.6.1 Global Receptor Internalization Assays Market Revenue, 2012 – 2022 (USD Million)
4.7 cAMP Assays
      4.7.1 Global cAMP Assays Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 5 Global G-Protein Coupled Receptors (GPCRs) Market, by Therapeutic Areas
5.1 Introduction
      5.1.1 Global GPCRs Market Revenue, by Therapeutic Areas, 2012 – 2022 (USD Million)
      5.1.2 Comparative Analysis: Global GPCRs Market Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)
5.2 Cardiovascular System
      5.2.1 Global GPCR Assays in Cardiovascular Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.3 Central Nervous System (CNS)
      5.3.1 Global GPCR Assays in CNS Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.4 Respiratory System
      5.4.1 Global GPCR Assays in Respiratory Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.5 Immune System
      5.5.1 Global GPCR Assays in Immune System Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.6 Reproductive System
      5.6.1 Global GPCR Assays in Reproductive System Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.7 Oncology
      5.7.1 Global GPCR Assays in Oncology Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.8 Other Therapeutic Areas
      5.8.1 Global GPCR Assays in Other Therapeutic Areas Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 6 Global G-Protein Coupled Receptors (GPCRs) Market, by Geography
6.1 Introduction
      6.1.1 Global GPCRs Market Revenue, by Geography, 2012 – 2022 (USD Million)
6.2 North America
      6.2.1 North America GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
      6.2.2 United States
              6.2.2.1 United States GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.2.3 Canada
              6.2.3.1 Canada GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.3 Europe
      6.3.1 Europe GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
      6.3.2 The United Kingdom
              6.3.2.1 United Kingdom GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.3.3 Germany
              6.3.3.1 Germany GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.3.4 France
              6.3.4.1 France GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.3.5 Rest of Europe
              6.3.5.1 Rest of Europe GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.4 Asia Pacific
      6.4.1 Asia Pacific GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
      6.4.2 China
             6.4.2.1 China GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.4.3 Japan
             6.4.3.1 Japan GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.4.4 India
             6.4.4.1 India GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.4.5 Rest of Asia Pacific
              6.4.5.1 Rest of Asia Pacific GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 Rest of the World GPCRs Market Revenue, by Geography, 2012 – 2022 (USD Million)
      6.5.2 Latin America
             6.5.2.1 Latin America GPCRs Market Revenue, 2012 – 2022 (USD Million)      
      6.5.3 Middle East
              6.5.3.1 Middle East GPCRs Market Revenue, 2012 – 2022 (USD Million)
      6.5.4 Africa
             6.5.4.1 Africa GPCRs Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 7 Recommendations
7.1 Develop Technologically Advanced GPCR Assays, Assay Systems and Platforms to Create Future Growth Opportunities
7.2 Target Emerging Economies of the World for Higher Benefits
7.3 Collaborate to Strengthen Market Presence
 
Chapter 8 Company Profiles
8.1 Abcam plc
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Becton, Dickinson and Company
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent developments
8.3 Cisbio Bioassays
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 DiscoveRx Corporation
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 EMD Millipore Corporation
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Enzo Life Sciences, Inc.
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 HD Biosciences Co. Ltd.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 PerkinElmer, Inc.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Promega Corporation
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 QIAGEN
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Sigma-Aldrich Corporation
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Thermo Fisher Scientific, Inc.
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global G-Protein Coupled Receptors (GPCRs) Market
TABLE 2 Global GPCRs Market Revenue, by Assay Type, 2012 – 2022 (USD Million)
TABLE 3 Global GPCRs Market Revenue, by Therapeutic Areas, 2012 – 2022 (USD Million)
TABLE 4 Global GPCRs Market Revenue, by Geography, 2012 – 2022 (USD Million)
TABLE 5 North America GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 6 Europe GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 7 Asia Pacific GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 8 Rest of the World GPCRs Market Revenue, by Geography, 2012 – 2022 (USD Million)
List of Figures
 
FIG. 1 G-Protein Coupled Receptors (GPCRs): Market Segmentation
FIG. 2 Global GPCRs Market Revenue, by Assay Type, 2013 (USD Million)
FIG. 3 Global GPCRs Market Revenue, by Therapeutic Areas, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global GPCRs Market Revenue, by Geography, 2013 & 2022 (Value %)
FIG. 5 Porter’s Five Forces Analysis: Global GPCRs Market
FIG. 6 Value Chain Analysis: Global GPCRs Market
FIG. 7 Market Attractiveness Analysis: Global GPCRs Market, by Geography, 2013
FIG. 8 Market Share Analysis, by Key Players: Global GPCRs Market, 2013 (Value %)
FIG. 9 Comparative Analysis: Global GPCRs Market Revenue, by Assay Type, 2013 & 2022 (Value %)
FIG. 10 Global Calcium Level Detection Assays Market Revenue, 2012 – 2022 (USD Million)
FIG. 11 Global GTPγS Binding Assays Market Revenue, 2012 – 2022 (USD Million)
FIG. 12 Global cGMP Assays Market Revenue, 2012 – 2022 (USD Million)
FIG. 13 Global Reporter Gene Assays Market Revenue, 2012 – 2022 (USD Million)
FIG. 14 Global Receptor Internalization Assays Market Revenue, 2012 – 2022 (USD Million)
FIG. 15 Global cAMP Assays Market Revenue, 2012 – 2022 (USD Million)
FIG. 16 Comparative Analysis: Global GPCRs Market Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)
FIG. 17 Global GPCR Assays in Cardiovascular Therapeutics Market Revenue, 2012 – 2022 (USD Million)
FIG. 18 Global GPCR Assays in CNS Therapeutics Market Revenue, 2012 – 2022 (USD Million)
FIG. 19 Global GPCR Assays in Respiratory Therapeutics Market Revenue, 2012 – 2022 (USD Million)
FIG. 20 Global GPCR Assays in Immune System Therapeutics Market Revenue, 2012 – 2022 (USD Million)
FIG. 21 Global GPCR Assays in Reproductive System Therapeutics Market Revenue, 2012 – 2022 (USD Million)
FIG. 22 Global GPCR Assays in Oncology Therapeutics Market Revenue, 2012 – 2022 (USD Million)
FIG. 23 Global GPCR Assays in Other Therapeutic Areas Market Revenue, 2012 – 2022 (USD Million)
FIG. 24 United States GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 25 Canada GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 26 United Kingdom GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 27 Germany GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 28 France GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 29 Rest of Europe GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 30 China GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 31 Japan GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 32 India GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 33 Rest of Asia Pacific GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 34 Latin America GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 35 Middle East GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 36 Africa GPCRs Market Revenue, 2012 – 2022 (USD Million)
FIG. 37 Abcam plc: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 38 BD Biosciences: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 39 EMD Millipore Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 40 Enzo Life Sciences, Inc.: Annual Revenue, 2011 – 2013 (USD million)
FIG. 41 PerkinElmer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 42 QIAGEN: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 43 Sigma-Aldrich Corporation: Annual Revenue, 2011 – 2013 (USD million)
FIG. 44 Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

G-Protein Coupled Receptors (GPCRs) Market